Authors:
HAAS C
STRAUSS G
MOLDENHAUER G
IORIO RM
SCHIRRMACHER V
Citation: C. Haas et al., BISPECIFIC ANTIBODIES INCREASE T-CELL STIMULATORY CAPACITY IN-VITRO OF HUMAN AUTOLOGOUS VIRUS-MODIFIED TUMOR VACCINE, Clinical cancer research, 4(3), 1998, pp. 721-730
Authors:
HAAS C
STRAUSS G
MOLDENHAUER G
IORIO RM
SCHIRRMACHER V
Citation: C. Haas et al., BISPECIFIC ANTIBODIES INCREASE T-CELL STIMULATORY CAPACITY IN-VITRO OF HUMAN AUTOLOGOUS VIRUS-MODIFIED TUMOR VACCINE, Clinical cancer research, 4(3), 1998, pp. 721-730
Citation: V. Schirrmacher et al., ANTAGONISTIC EFFECTS OF SYSTEMIC INTERLEUKIN-2 ON IMMUNE T-CELL-MEDIATED GRAFT-VERSUS-LEUKEMIA REACTIVITY, Clinical cancer research, 4(11), 1998, pp. 2635-2645
Authors:
KING JA
BRIDGER JM
LOCHELT M
LICHTER P
SCHULZ TF
SCHIRRMACHER V
KHAZAIE K
Citation: Ja. King et al., NUCLEOCYTOPLASMIC TRANSPORT OF HTLV-1 RNA IS REGULATED BY 2 INDEPENDENT LTR ENCODED NUCLEAR RETENTION ELEMENTS, Oncogene, 16(25), 1998, pp. 3309-3316
Citation: K. Jurianz et al., SUPERIORITY OF THE EAR PINNA OVER A SUBCUTANEOUS TUMOR INOCULATION SITE FOR INDUCTION OF A TH1-TYPE CYTOKINE RESPONSE, Cancer immunology and immunotherapy, 45(6), 1998, pp. 327-333
Authors:
LOS M
KHAZAIE K
SCHULZEOSTHOFF K
BAEUERLE PA
SCHIRRMACHER V
CHLICHLIA K
Citation: M. Los et al., HUMAN T-CELL LEUKEMIA VIRUS-I (HTLV-I) TAX-MEDIATED APOPTOSIS IN ACTIVATED T-CELLS REQUIRES AN ENHANCED INTRACELLULAR PROOXIDANT STATE, The Journal of immunology (1950), 161(6), 1998, pp. 3050-3055
Authors:
SCHIRRMACHER V
BEUTNER U
BUCUR M
UMANSKY V
ROCHA M
VONHOEGEN P
Citation: V. Schirrmacher et al., LOSS OF ENDOGENOUS MOUSE MAMMARY-TUMOR VIRUS SUPERANTIGEN INCREASES TUMOR RESISTANCE, The Journal of immunology (1950), 161(2), 1998, pp. 563-570
Authors:
WANG JM
CHERTOV O
PROOST P
LI JJ
MENTON P
XU LL
SOZZANI S
MANTOVANI A
GONG WH
SCHIRRMACHER V
VANDAMME J
OPPENHEIM JJ
Citation: Jm. Wang et al., PURIFICATION AND IDENTIFICATION OF CHEMOKINES POTENTIALLY INVOLVED INKIDNEY-SPECIFIC METASTASIS BY A MURINE LYMPHOMA VARIANT - INDUCTION OF MIGRATION AND NF-KAPPA-B ACTIVATION, International journal of cancer, 75(6), 1998, pp. 900-907
Authors:
KING JA
BRIDGER JM
GOUNARI F
LICHTER P
SCHULZ TF
SCHIRRMACHER V
KHAZAIE K
Citation: Ja. King et al., THE EXTENDED PACKAGING SEQUENCE OF MOMLV CONTAINS A CONSTITUTIVE MESSENGER-RNA NUCLEAR EXPORT FUNCTION, FEBS letters, 434(3), 1998, pp. 367-371
Authors:
UMANSKY V
HEHNER SP
DUMONT A
HOFMANN TG
SCHIRRMACHER V
DROGE W
SCHMITZ ML
Citation: V. Umansky et al., COSTIMULATORY EFFECT OF NITRIC-OXIDE ON ENDOTHELIAL NF-KAPPA-B IMPLIES A PHYSIOLOGICAL SELF-AMPLIFYING MECHANISM, European Journal of Immunology, 28(8), 1998, pp. 2276-2282
Authors:
LILIENSIEK B
ROCHA M
UMANSKY V
BENNER A
LIN J
ZIEGLER R
NAWROTH PP
SCHIRRMACHER V
Citation: B. Liliensiek et al., IDENTIFICATION OF 4 GENES IN ENDOTHELIAL-CELLS WHOSE EXPRESSION IS AFFECTED BY TUMOR-CELLS AND HOST IMMUNE STATUS - A STUDY IN EX VIVO-ISOLATED ENDOTHELIAL-CELLS, Blood, 92(9), 1998, pp. 3394-3404
Authors:
CHLICHLIA K
PETER ME
ROCHA M
SCAFFIDI C
BUCUR M
KRAMMER PH
SCHIRRMACHER V
UMANSKY V
Citation: K. Chlichlia et al., CASPASE ACTIVATION IS REQUIRED FOR NITRIC OXIDE-MEDIATED, CD95(APO-1 FAS)-DEPENDENT AND INDEPENDENT APOPTOSIS IN HUMAN NEOPLASTIC LYMPHOID-CELLS/, Blood, 91(11), 1998, pp. 4311-4320
Citation: V. Schirrmacher et al., VIRUS POTENTIATION OF TUMOR VACCINE T-CELL STIMULATORY CAPACITY REQUIRES CELL-SURFACE BINDING BUT NOT INFECTION, Clinical cancer research, 3(7), 1997, pp. 1135-1148
Citation: C. Haas et V. Schirrmacher, EFFECTIVE INTRODUCTION OF T-CELL COSTIMULATORY MOLECULES INTO VIRUS MODIFIED TUMOR-CELL VACCINES BY MODIFICATION WITH BISPECIFIC ANTIBODIES, International journal of oncology, 11(5), 1997, pp. 951-957
Citation: V. Schirrmacher et al., INTRA-PINNA INDUCTION OF SPECIFIC ANTITUMOR IMMUNE T-CELL FUNCTIONS -EFFECT OF EAR RESECTION AFTER ANTIGEN APPLICATION, International journal of oncology, 11(2), 1997, pp. 227-233
Authors:
NAUJOCKS G
SERWE M
BAYER TA
SCHIRRMACHER V
Citation: G. Naujocks et al., ADOPTIVE TRANSFER VIA IMMUNE T-LYMPHOCYTES OF EFFECTIVE ANTITUMOR IMMUNITY AGAINST A MALIGNANT RAT GLIOMA IN THE BRAIN, International journal of oncology, 11(2), 1997, pp. 249-254
Authors:
ROCHA M
UMANSKY V
SCHIRRMACHER V
ELICES MJ
Citation: M. Rocha et al., IN-SITU DOWN-REGULATION OF VLA-4 INTEGRIN CELL-SURFACE EXPRESSION DURING LYMPHOMA GROWTH AND LIVER METASTASIS, International journal of oncology, 10(3), 1997, pp. 457-464
Citation: V. Umansky et al., ACTIVATED ENDOTHELIAL-CELLS INDUCE APOPTOSIS IN LYMPHOMA-CELLS - ROLEOF NITRIC-OXIDE, International journal of oncology, 10(3), 1997, pp. 465-471
Citation: V. Schirrmacher et C. Haas, BISPECIFIC ANTIBODY MODIFIED TUMOR VACCINE FOR HUMAN T-CELL STIMULATION, European journal of cancer, 33, 1997, pp. 36-36
Citation: V. Schirrmacher et C. Haas, BISPECIFIC ANTIBODY MODIFICATION OF HUMAN CANCER VACCINES - AN EFFECTIVE ALTERNATIVE TO SOMATIC THERAPY, Cancer gene therapy, 4(5), 1997, pp. 314-314
Authors:
FICHTNER KP
SCHIRRMACHER V
GRIESBACH A
HULL WE
Citation: Kp. Fichtner et al., IN-VIVO H-1-NMR MICROIMAGING WITH RESPIRATORY TRIGGERING FOR MONITORING ADOPTIVE IMMUNOTHERAPY OF METASTATIC MOUSE LYMPHOMA, Magnetic resonance in medicine, 38(3), 1997, pp. 440-455